Home8WK • FRA
add
Abera Bioscience AB
Previous close
€0.51
Day range
€0.51 - €0.52
Year range
€0.34 - €0.84
Avg Volume
3.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | -902.00K | -120.02% |
Operating expense | 7.96M | 75.30% |
Net income | -8.80M | -4,454.95% |
Net profit margin | 975.28 | 21,669.64% |
Earnings per share | — | — |
EBITDA | -8.80M | -79,936.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.49M | 285.70% |
Total assets | 28.57M | 110.00% |
Total liabilities | 9.28M | 87.59% |
Total equity | 19.29M | — |
Shares outstanding | 18.63M | — |
Price to book | 0.49 | — |
Return on assets | -70.77% | — |
Return on capital | -93.58% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.80M | -4,454.95% |
Cash from operations | -815.00K | -121.79% |
Cash from investing | -72.00K | 89.50% |
Cash from financing | 1.20M | 1,814.29% |
Net change in cash | 313.00K | -89.51% |
Free cash flow | 2.37M | -16.25% |
About
Founded
2012
Website
Employees
5
